Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)
Rheumatoid Arthritis
About this trial
This is an interventional treatment trial for Rheumatoid Arthritis focused on measuring Arcoxia
Eligibility Criteria
Inclusion Criteria: Patient with diagnosed rheumatoid arthritis (RA) for at least 6 months prior who is otherwise judged to be in general good health and who is currently taking nonsteroidal anti-inflammatory drugs (NSAIDS) to treat his/her RA symptoms Patient will need to stop taking these medications in order to participate, but can continue taking his/her other anti-rheumatic medications as long as they have been stable for certain periods of time Exclusion Criteria: Patients with a disease or medical condition(s) that could worsen or interfere with the evaluation of the effectiveness of study medication are not allowed to participate
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Experimental
Experimental
Experimental
Experimental
Placebo Comparator
Experimental
Active Comparator
Period I: 1
Period I: 2
Period I: 3
Period I: 4
Period I: 5
Period II: 1
Period II: 2
etoricoxib
etoricoxib
etoricoxib
etoricoxib
Placebo
etoricoxib
diclofenac